Assessing the Effect of a Contouring Protocol on Postprostatectomy Radiotherapy Clinical Target Volumes and Interphysician Variation


      To compare postprostatectomy clinical target volume (CTV) delineation before and after the introduction of a contouring protocol and to investigate its effect on interphysician variability

      Methods and Materials

      Six site-specialized radiation oncologists independently delineated a CTV on the computed tomography (CT) scans of 3 patients who had received postprostatectomy radiotherapy. At least 3 weeks later this was repeated, but with the physicians adhering to the contouring protocol from the Medical Research Council's Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) trial. The volumes obtained before and after the protocol were compared and the effect of the protocol on interphysician variability assessed.


      An increase in mean CTV for all patients of 40.7 to 53.9cm3 was noted as a result of observing the protocol, with individual increases in the mean CTV of 65%, 15%, and 24% for Patients 1, 2, and 3 respectively. A reduction in interphysician variability was noted when the protocol was used.


      Substantial interphysician variation in target volume delineation for postprostatectomy radiotherapy exists, which can be reduced by the use of a contouring protocol. The RADICALS contouring protocol increases the target volumes when compared with those volumes typically applied at our center. The effect of treating larger volumes on the therapeutic ratio and resultant toxicity should be carefully monitored, particularly if the same dose-response as documented in radical prostate radiotherapy applies to the adjuvant and salvage setting. Prostate cancer, Postprostatectomy, Radiotherapy, Target volume.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bolla M.
        • van Poppel H.
        • Collette L.
        • et al.
        Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911).
        Lancet. 2005; 366: 572-578
        • Thompson I.M.
        • Tangen C.M.
        • Paradelo J.
        • et al.
        Adjuvant radiotherapy for pathologically advanced prostate cancer.
        J Am Med Assoc. 2006; 19: 2329-2335
        • Wiegel T.
        • Bottke D.
        • Willich N.
        • et al.
        Phase III results of adjuvant radiotherapy (RT) versus “wait and see” (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP)(ARO 96-02/AUO AP 09/95).
        J Clin Oncol. 2005; 23 ([Abstract]): 381
        • Swanson G.P.
        • Thompson I.M.
        • Tangen C.
        • et al.
        Update of SWOG 8794: Adjuvant radiotherapy for pT3 prostate cancer improves metastasis free survival.
        Int J Radiat Oncol Biol Phys. 2008; 72: S31
        • Poortmans P.
        • Bossi A.
        • Vandeputte K.
        • Bosset M.
        • et al.
        Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.
        Radiother Oncol. 2007; 84: 121-127
        • Sidhom M.A.
        • Kneebone A.B.
        • Lehman M.
        • et al.
        Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group.
        Radiother Oncol. 2008; 88: 10-19
        • Wiltshire K.L.
        • Brock K.K.
        • Haider M.A.
        • et al.
        Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy.
        Int J Radiat Oncol Biol Phys. 2007; 69: 1090-1099
        • Wiltshire K.
        • Brock K.
        • Haider M.
        • et al.
        Achieving a consensus definition for anatomic boundaries of the CTV (prostate bed): Methods and observer reproducibility using MRI.
        Int J Radiat Oncol Biol Phys. 2006; 66: S208
        • Parker C.
        • Clarke N.
        • Logue J.
        • et al.
        RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery).
        Clin Oncol. 2007; 19: 167-171
        • Foppiano F.
        • Franzone P.
        • Bertoni F.
        • et al.
        AIRO PROS 01-04 multi-centric study in contouring CTV for conformal radiotherapy after radical prostatectomy.
        Int J Radiat Oncol Biol Phys. 2006; 66 ([Abstract]): S358
        • Michalski J.M.
        • Lawton C.
        • El-Naqa I.
        • et al.
        Variation in the definition of clinical target volumes for postoperative conformal radiation therapy of prostate cancer.
        Int J Radiat Oncol Biol Phys. 2007; 69 ([Abstract]): S326
        • King C.R.
        • Kapp D.S.
        Radiotherapy after prostatectomy: Is the evidence for dose escalation out there.
        Int J Radiat Oncol Biol Phys. 2008; 71: 346-350
        • King C.R.
        Spiotto. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy.
        Int J Radiat Oncol Biol Phys. 2008; 71: 23-27


      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.